J2265 HCPCS Level II code: Injection, minocycline hydrochloride, 1 mg
J2265 is the HCPCS code for “Injection, minocycline hydrochloride, 1 mg” in CMS’s October 2026 release, in effect from Oct 1, 2026.
Official description
J2265Injection, minocycline hydrochloride, 1 mg
Short description: Minocycline hydrochloride
HCPCS · United States
Medicare details
The indicators CMS publishes with J2265 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Carrier judgment
- Medicare pricing
- Drugs
- ASC
- Approved for ambulatory surgical centers
- Type of service
- Medical care; Lump sum purchase of DME, prosthetics, orthotics
- BETOS category
- Other drugs
- Added
- Jan 1, 2012
Where J2265 sits
- 1J codesDrugs administered other than orally
- 2Active code J2265Injection, minocycline hydrochloride, 1 mg
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
What does HCPCS code J2265 mean?
J2265 is the HCPCS code for “Injection, minocycline hydrochloride, 1 mg” in CMS’s HCPCS Level II October 2026 release.
Does Medicare cover J2265?
CMS lists J2265’s Medicare coverage as “Carrier judgment” and its pricing as “Drugs”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside J2265
All J codesJ2249Injection, remimazolam, 1 mgJ2250Injection, midazolam hydrochloride, per 1 mgJ2251Injection, midazolam in 0.9% sodium chloride, intravenous, not therapeutically equivalent to j2250, 1 mgJ2252Injection, midazolam in 0.8% sodium chloride, intravenous, not therapeutically equivalent to j2250, 1 mgJ2253Injection, midazolam (seizalam), 1 mgJ2260Injection, milrinone lactate, 5 mgJ2267Injection, mirikizumab-mrkz, 1 mgJ2270Injection, morphine sulfate, up to 10 mgJ2271Injection, morphine sulfate, 100mgJ2272Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mgJ2274Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mgJ2275Injection, morphine sulfate (preservative-free sterile solution), per 10 mg